Newly Diagnosed Primary Amyloidosis
Oncology·MeSH: Immunoglobulin Light-chain Amyloidosis
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Daratumumab | FATE THERAPEUTICS INC (FATE) |
Phase 1(1)
| Drug | Company |
|---|---|
| Ixazomib | FATE THERAPEUTICS INC (FATE) |
Compare drugs
Frequently asked questions
How many drugs are in development for Newly Diagnosed Primary Amyloidosis?
BioSniper tracks 2 drugs in development for Newly Diagnosed Primary Amyloidosis across 1 company.
How many clinical trials target Newly Diagnosed Primary Amyloidosis?
There are 1 clinical trial targeting Newly Diagnosed Primary Amyloidosis tracked by BioSniper.
Deep-dive into Newly Diagnosed Primary Amyloidosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis